pravastatin has been researched along with Fatty Liver, Nonalcoholic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cherrington, NJ; Clarke, JD; Csanaky, IL; Toth, EL | 1 |
| Cherrington, NJ; Clarke, JD; Goedken, MJ; Hardwick, RN; Klaassen, CD; Lake, AD; Lickteig, AJ | 1 |
2 other study(ies) available for pravastatin and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Interaction of Oatp1b2 expression and nonalcoholic steatohepatitis on pravastatin plasma clearance.
Topics: Animals; Disease Models, Animal; Gene Dosage; Gene Expression; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Metabolic Clearance Rate; Mice, Inbred C57BL; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Pravastatin | 2020 |
Synergistic interaction between genetics and disease on pravastatin disposition.
Topics: Animals; Biological Transport, Active; Choline; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Liver-Specific Organic Anion Transporter 1; Male; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscles; Non-alcoholic Fatty Liver Disease; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Pravastatin | 2014 |